Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has announced that Yarra Funds Management Limited and its associated entities have ceased to be substantial holders, following a series of transactions between September 19 and October 2, 2024. During this period, the group acquired and disposed of shares resulting in a net decrease in their voting power. This marks a significant change in the company’s ownership structure that could interest investors.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
